The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
A comprehensive catalogue of somatic mutations from a human cancer genome
Open accessAbstract
All cancers carry somatic mutations. A subset of these somatic alterations, termed driver mutations, confer selective growth advantage and are implicated in cancer development, whereas the remainder are passengers. Here we have sequenced the genomes of a malignant melanoma and a lymphoblastoid cell line from the same person, providing the first comprehensive catalogue of somatic mutations from an individual cancer. The catalogue provides remarkable insights into the forces that have shaped this cancer genome. The dominant mutational signature reflects DNA damage due to ultraviolet light exposure, a known risk factor for malignant melanoma, whereas the uneven distribution of mutations across the genome, with a lower prevalence in gene footprints, indicates that DNA repair has been preferentially deployed towards transcribed regions. The results illustrate the power of a cancer genome sequence to reveal traces of the DNA damage, repair, mutation and selection processes that were operative years before the cancer became symptomatic. The two cancer genome sequences presented in this issue demonstrate how next-generation sequencing technologies can inform us about mutational processes, repair pathways and gene networks associated with cancer development. First, the genome of a cell line derived from a bone marrow metastasis in a patient who had small-cell lung cancer. This cancer is typical of the type induced by smoking, and the sequence contains mutation signatures characteristic of some of the more than 60 carcinogens present in tobacco smoke. The second paper compares the whole genome sequence of a melanoma cell line to a lymphoblastoid cell line from the same individual. This, the first complete mutational analysis of a solid tumour, reveals a dominant mutational signature reflecting DNA damage due to exposure to ultraviolet light. Here, the genomes of a malignant melanoma and a lymphoblastoid cell line from the same person are sequenced, providing the first comprehensive catalogue of somatic mutations from an individual cancer. The data provide insight into the causes of tumour formation and the development of the cancer genome, with the dominant mutational signature reflecting DNA damage due to ultraviolet light exposure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Melanoma somatic mutations consist almost entirely of C → T transitions, 28% of which are TCC → T mutations (19,31).”
From Evidence for recent, population-specific evolution of the human mutation rate (2015) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Circos: An information aesthetic for comparative genomicsPreprint
Krzywinski, M. I., Schein, J. E., Birol, İ., Connors, J. M., Gascoyne, R. D., Horsman, D. E., Jones, S. J. M., & Marra, M. A. (2009) · Genome Research · doi:10.1101/gr.092759.109 · Cited by 11,029
Velvet: Algorithms for de novo short read assembly using de Bruijn graphsPreprint
Zerbino, D. R., & Birney, E. (2008) · Genome Research · doi:10.1101/gr.074492.107 · Cited by 9,575
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Genome sequencing in microfabricated high-density picolitre reactors
Margulies, M., Egholm, M., Altman, W. E., Attiya, S., Bader, J. S., Bemben, L. A., Berka, J., Braverman, M. S., Chen, Y.-J., Chen, Z., et al. (2005) · Nature · doi:10.1038/nature03959 · Cited by 7,693
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citationAccurate whole human genome sequencing using reversible terminator chemistry
Bentley, D. R., Balasubramanian, S., Swerdlow, H. P., Smith, G. P., Milton, J., Brown, C. G., Hall, K. P., Evers, D. J., Barnes, C. L., Bignell, H. R., et al. (2008) · Nature · doi:10.1038/nature07517 · Cited by 3,684
Self-citationStratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,625
Self-citationA census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Self-citation
Flagged first, then by citations
1 of the 43 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–700 of 1,001
Germ cell mutagens: Risk assessment challenges in the 21st century
Singer, T. M., & Yauk, C. L. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20613 · Cited by 41
Beal, M. A., Glenn, T. C., & Somers, C. M. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.11.002 · Cited by 41
ADA-07 Suppresses Solar Ultraviolet–Induced Skin Carcinogenesis by Directly Inhibiting TOPK
Gao, G., Zhang, T., Wang, Q., Reddy, K., Chen, H., Yao, K., Wang, K., Roh, E., Zykova, T. A., Ma, W., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0212 · Cited by 43
College tanning behaviors, attitudes, beliefs, and intentions: A systematic review of the literature
Gambla, W. C., Fernandez, A. M., Gassman, N. R., Tan, M. C. B., & Daniel, C. L. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.08.029 · Cited by 42
Trajectory and uniqueness of mutational signatures in yeast mutators
Loeillet, S., Herzog, M., Puddu, F., Legoix, P., Baulande, S., Jackson, S. P., & Nicolas, A. G. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011332117 · Cited by 42
The Mutator Phenotype in Cancer: Molecular Mechanisms and Targeting Strategies
Prindle, M. J., Fox, E., & Loeb, L. A. (2010) · Current Drug Targets · doi:10.2174/1389450111007011296 · Cited by 43
Delving into somatic variation in sporadic melanoma
Walia, V., Mu, E. W., Lin, J., & Samuels, Y. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.00976.x · Cited by 41
eLCR: electrochemical detection of single DNA base changes via Ligase Chain Reaction
Wee, E. J. H., Shiddiky, M. J. A., Brown, M. A., & Trau, M. (2012) · Chemical Communications · doi:10.1039/c2cc35841g · Cited by 41
Clinical cancer genomics: how soon is now?
Taylor, B. S., & Ladanyi, M. (2010) · The Journal of Pathology · doi:10.1002/path.2794 · Cited by 41
Giotopoulos, G., van der Weyden, L., Osaki, H., Rust, A. G., Gallipoli, P., Meduri, E., Horton, S. J., Chan, W.-I., Foster, D., Prinjha, R. K., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20141661 · Cited by 41
Ultraviolet Photobiology in Dermatology
Christensen, L., Suggs, A. K., & Baron, E. D. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-56017-5_8 · Cited by 42
Bioinformatics Analysis of Whole Exome Sequencing Data
Ulintz, P., Wu, W.-S., & Gates, C. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8876-1_21 · Cited by 41
Breakthrough concepts in immune-oncology: Cancer vaccines at the bedside
Roy, S., Sethi, T. K., Taylor, D., Kim, Y. J., & Johnson, D. B. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.5bt0420-585rr · Cited by 44
Jin, S., Pettinga, D., Johnson, J. S., Li, P., & Pfeifer, G. P. (2021) · Science Advances · doi:10.1126/sciadv.abi6508 · Cited by 45
Guanine holes are prominent targets for mutation in cancer and inherited disease
Bacolla, A., Temiz, N. A., Yi, M., Ivanic, J., Cer, R. Z., Donohue, D. E., Ball, E. V., Mudunuri, U. S., Wang, G., Jain, A., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003816 · Cited by 40
Tumor-Specific Antigens and Immunologic Adjuvants in Cancer Immunotherapy
Seremet, T., Brasseur, F., & Coulie, P. G. (2011) · The Cancer Journal · doi:10.1097/ppo.0b013e3182326004 · Cited by 40
Clarke, A. C., Prost, S., Stanton, J. L., White, W. T. J., Kaplan, M. E., & Matisoo-Smith, E. A. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-68 · Cited by 40
Challenges in identifying cancer genes by analysis of exome sequencing data
Hofree, M., Carter, H. K., Kreisberg, J. F., Bandyopadhyay, S., Mischel, P. S., Friend, S. H., & Ideker, T. (2016) · Nature Communications · doi:10.1038/ncomms12096 · Cited by 40
Schulz, L., Torres-Diz, M., Cortés-López, M., Hayer, K. E., Asnani, M., Tasian, S. K., Barash, Y., Sotillo, E., Zarnack, K., König, J., et al. (2021) · Genome biology · doi:10.1186/s13059-021-02411-1 · Cited by 38
Next-generation sequencing applied to molecular diagnostics
Natrajan, R., & Reis-Filho, J. S. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.18 · Cited by 41
Precision Medicine in Breast Cancer: Genes, Genomes, and the Future of Genomically Driven Treatments
Stover, D. G., & Wagle, N. (2015) · Current Oncology Reports · doi:10.1007/s11912-015-0438-0 · Cited by 39
Wei, X., Moncada-Pazos, Á., Cal, S., Soria‐Valles, C., Gartner, J. J., Rudloff, U., Lin, J., Program, N. C. S., Rosenberg, S. A., López-Otı́n, C., et al. (2011) · Human Mutation · doi:10.1002/humu.21477 · Cited by 39
Using genetics and genomics strategies to personalize therapy for cancer: Focus on melanoma
Nathanson, K. L. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.04.017 · Cited by 39
A Network of Cancer Genes with Co-Occurring and Anti-Co-Occurring Mutations
Cui, Q. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013180 · Cited by 39
A Noncanonical Flt3ITD/NF-κB Signaling Pathway Represses DAPK1 in Acute Myeloid Leukemia
Shanmugam, R., Gade, P., Wilson-Weekes, A., Sayar, H., Suvannasankha, A., Goswami, C. P., Li, L., Gupta, S. K., Cardoso, A. A., Baghdadi, T. A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3022 · Cited by 40
NGS catalog: A database of next generation sequencing studies in humans
Xia, J., Wang, Q., Jia, P., Wang, B., Pao, W. J., & Zhao, Z. (2012) · Human Mutation · doi:10.1002/humu.22096 · Cited by 39
DNA methylation subgroups in melanoma are associated with proliferative and immunological processes
Lauss, M., Ringnér, M., Karlsson, A., Harbst, K., Busch, C., Geisler, J., Lønning, P. E., Staaf, J., & Jönsson, G. B. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0147-4 · Cited by 40
Circulating free DNA in the era of precision oncology: Pre‐ and post‐analytical concerns
Lu, J., & Liang, Z. (2016) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2016.12.001 · Cited by 39
DNA methylation markers in the diagnosis and prognosis of common leukemias
Jiang, H., Ou, Z., He, Y., Yu, M., Wu, S., Li, G. L., Zhu, J., Zhang, R., Wang, J., Zheng, L., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0090-5 · Cited by 39
Laughery, M. F., Brown, A., Bohm, K. A., Sivapragasam, S., Morris, H. S., Tchmola, M., Washington, A. D., Mitchell, D., Mather, S., Malc, E. P., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108401 · Cited by 37
Mutated genes, pathways and processes in tumours
Baudot, A., de la Torre, V., & Valencia, A. (2010) · EMBO Reports · doi:10.1038/embor.2010.133 · Cited by 39
Human genome at ten: The sequence explosion
(2010) · Nature · doi:10.1038/464670a · Cited by 40
Yin, S., Yang, J., Lin, B., Deng, W., Zhang, Y., Yi, X., Shi, Y., Tao, Y., Cai, J., Wu, C., et al. (2014) · Scientific Reports · doi:10.1038/srep06036 · Cited by 42
Mahler, H. I. M., Kulik, J. A., Gerrard, M., & Gibbons, F. X. (2013) · Psychology and Health · doi:10.1080/08870446.2013.777966 · Cited by 38
Integrated analysis of recurrent properties of cancer genes to identify novel drivers
D’Antonio, M., & Ciccarelli, F. D. (2013) · Genome biology · doi:10.1186/gb-2013-14-5-r52 · Cited by 36
[Ultraviolet A-induced DNA damage: role in skin cancer].
Béani, J. (2014) · PubMed · Cited by 38
Simbulan-Rosenthal, C. M., Dougherty, R., Vakili, S., Ferraro, A., Kuo, L., Alobaidi, R., Aljehane, L., Gaur, A., Sykora, P., Glasgow, E. F., et al. (2019) · Cancers · doi:10.3390/cancers11101490 · Cited by 36
Botoseneanu, A., Alexander, J. A., & Banaszak‐Holl, J. (2011) · Health Education & Behavior · doi:10.1177/1090198110389711 · Cited by 38
Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development
Piao, M., Cao, H., He, N., Xu, M., Dong, W., Wang, W., Wang, B., & Zhou, B. R. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1124285 · Cited by 38
Pharmacogenomics and targeted therapy of cancer: Focusing on non-small cell lung cancer
Haghgoo, S. M., Allameh, A., Mortaz, E., Garssen, J., Folkerts, G., Barnes, P. J., & Adcock, I. M. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.02.029 · Cited by 39
Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy
Savonarola, A., Palmirotta, R., Guadagni, F., & Silvestris, F. (2012) · The Pharmacogenomics Journal · doi:10.1038/tpj.2012.28 · Cited by 36
Structure-Functional Prediction and Analysis of Cancer Mutation Effects in Protein Kinases
Dixit, A., & Verkhivker, G. M. (2014) · Computational and Mathematical Methods in Medicine · doi:10.1155/2014/653487 · Cited by 37
UVA, UVB and incidence of cutaneous malignant melanoma in Norway and Sweden
Moan, J. E., Baturaite, Z., Porojnicu, A. C., Dahlback, A., & Juzeniene, A. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp05215b · Cited by 37
Beyond the exome: the role of non-coding somatic mutations in cancer
Piraino, S. W., & Furney, S. J. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv561 · Cited by 39
Zhou, C., Dai, X., Chen, Y., Shen, Y., Lei, S., Xiao, T., Bartfai, T., Ding, J., & Wang, M. (2016) · Oncotarget · doi:10.18632/oncotarget.7313 · Cited by 37
How the environment shapes cancer genomes
Pfeifer, G. P. (2014) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000152 · Cited by 38
Kunz, M., & Hölzel, M. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9657-1 · Cited by 38
The Cancer Mutation D83V Induces an α-Helix to β-Strand Conformation Switch in MEF2B
Lei, X., Kou, Y., Fu, Y., Rajashekar, N., Shi, H., Wu, F., Xu, J., Luo, Y., & Chen, L. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.02.012 · Cited by 35
Self-citationPredicting the evolution of Escherichia coli by a data-driven approach
Wang, X., Zorraquino, V., Kim, M., Τσουκαλάς, Α., & Tagkopoulos, I. (2018) · Nature Communications · doi:10.1038/s41467-018-05807-z · Cited by 37
FDG PET/CT for Assessment of Immune Therapy: Opportunities and Understanding Pitfalls
Cho, S. Y., Huff, D. T., Jeraj, R., & Albertini, M. R. (2020) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2020.06.001 · Cited by 37
Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention
Manganelli, M., Guida, S., Ferretta, A., Pellacani, G., Porcelli, L., Azzariti, A., & Guida, G. (2021) · Genes · doi:10.3390/genes12071093 · Cited by 39
Genomic variant benchmark: if you cannot measure it, you cannot improve it
Majidian, S., Agustinho, D. P., Chin, C.-S., Sedlazeck, F. J., & Mahmoud, M. (2023) · Genome biology · doi:10.1186/s13059-023-03061-1 · Cited by 35
THE REFERENCE HUMAN GENOME DEMONSTRATES HIGH RISK OF TYPE 1 DIABETES AND OTHER DISORDERS
Chen, R., & Butte, A. J. (2010) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814335058_0025 · Cited by 35
Implication of ultraviolet light in the etiology of uveal melanoma: A review
Mallet, J. D., Gendron, S. P., Desgarnier, M. D., & Rochette, P. J. (2013) · Photochemistry and Photobiology · doi:10.1111/php.12161 · Cited by 38
Therapeutic implications of melanoma heterogeneity
Hachey, S. J., & Boiko, A. D. (2016) · Experimental Dermatology · doi:10.1111/exd.13002 · Cited by 36
Ng, B. Y. C., Wee, E. J. H., Woods, K., Anderson, W., Antaw, F., Tsang, H., West, N., & Trau, M. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b01685 · Cited by 23
Zhou, Y., Meng, X., Belle, J. H., Zhang, H., Kennedy, C. M., Al‐Hamdan, M. Z., Wang, J., & Liu, Y. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.06.074 · Cited by 39
Frontiers in Bladder Cancer Genomic Research
Li, Y., Sun, L., Guo, X., Mo, N., Zhang, J., & Li, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.670729 · Cited by 36
Rytelewski, M., Tong, J., Buensuceso, A. V., Leong, H. S., Vareki, S. M., Figueredo, R., Cresce, C. D., Wu, S. Y., Herbrich, S. M., Baggerly, K., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.05.017 · Cited by 36
Special techniques in surgical pathology
(2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06969-4.00023-4 · Cited by 36
High‐throughput sequencing of the melanoma genome
Kunz, M., Dannemann, M., & Kelso, J. F. (2012) · Experimental Dermatology · doi:10.1111/exd.12054 · Cited by 36
Stadler, J. T., Eder, J., Pratscher, B., Brandt, S., Schneller, D., Müllegger, R., Vogl, C., Trautinger, F., Brem, G., & Burgstaller, J. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142273 · Cited by 35
Kuhlen, M., & Borkhardt, A. (2015) · European Journal of Pediatrics · doi:10.1007/s00431-015-2565-x · Cited by 35
Váraljai, R., Horn, S., Sucker, A., Piercianek, D., Schmitt, V., Carpinteiro, A., Becker, K. A., REIFENBERGER, J., Roesch, A., Felsberg, J., et al. (2021) · Cancers · doi:10.3390/cancers13040731 · Cited by 36
Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy
Verdon, D. J., & Jenkins, M. R. (2021) · Cancers · doi:10.3390/cancers13164245 · Cited by 36
Examining clustered somatic mutations with SigProfilerClusters
Bergstrom, E. N., Kundu, M., Tbeileh, N., & Alexandrov, L. B. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac335 · Cited by 35
Selection and mutation in the “new” genetics: an emerging hypothesis
Gottlieb, B., Beitel, L. K., Alvarado, C., & Trifiro, M. A. (2010) · Human Genetics · doi:10.1007/s00439-010-0792-9 · Cited by 35
Tuna, M., & Amos, C. I. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.004 · Cited by 37
Second Primary Cancers – Causes, Incidence and the Future
Koubková, L., Hrstka, R., Dobeš, P., Vojtěšek, B., & Vyzula, R. (2014) · Klinicka onkologie · doi:10.14735/amko201411 · Cited by 35
Looking beyond drivers and passengers in cancer genome sequencing data
De, S., & Ganesan, S. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw677 · Cited by 36
Klinke, D. J., Kulkarni, Y. M., Wu, Y., & Byrne-Hoffman, C. N. N. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25238 · Cited by 35
The Non-Coding Oncogene: A Case of Missing DNA Evidence?
Shahrouki, P., & Larsson, E. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00170 · Cited by 34
Ranking insertion, deletion and nonsense mutations based on their effect on genetic information
Zia, A., & Moses, A. M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-299 · Cited by 34
Low-copy piggyBac transposon mutagenesis in mice identifies genes driving melanoma
Ni, T. K., Landrette, S. F., Bjornson, R. D., Bosenberg, M., & Xu, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314435110 · Cited by 35
Cockerell, C. J. (2012) · Dermatologic Clinics · doi:10.1016/j.det.2012.04.007 · Cited by 34
Jeck, W. R., Parker, J. S., Carson, C. C., Shields, J. M., Sambade, M. J., Peters, E. C., Burd, C. E., Thomas, N. E., Chiang, D. Y., Liu, W., et al. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12238 · Cited by 35
Ultraviolet radiation and cutaneous melanoma: a historical perspective
Autier, P., & Doré, J. (2019) · Melanoma Research · doi:10.1097/cmr.0000000000000609 · Cited by 38
Contrasting Determinants of Mutation Rates in Germline and Soma
Chen, C., Qi, H., Shen, Y., Pickrell, J. K., & Przeworski, M. (2017) · Genetics · doi:10.1534/genetics.117.1114 · Cited by 37
Guo, W.-F., Yu, X., Shi, Q., Liang, J., Zhang, S., & Zeng, T. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008962 · Cited by 34
Genomes, Populations and Diseases: Ethnic Genomics and Personalized Medicine
Степанов, В. А. (2010) · Acta Naturae · doi:10.32607/20758251-2010-2-4-15-30 · Cited by 33
Whole-exome sequencing of pediatric acute lymphoblastic leukemia
Lilljebjörn, H., Rissler, M., Lassen, C., Heldrup, J., Behrendtz, M., Mitelman, F., Johansson, B., & Fioretos, T. (2011) · Leukemia · doi:10.1038/leu.2011.333 · Cited by 33
Shull, A. Y., Clendenning, M., Ghoshal-Gupta, S., Farrell, C. L., Vangapandu, H. V., Dudas, L., Wilkerson, B. J., & Buckhaults, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058731 · Cited by 34
Helicobacter pylori Infection Predicts Favorable Outcome in Patients with Gastric Cancer
Wang, F., Sun, G., Zou, Y., Zhong, F., Ma, T., Li, X. Q., & Wu, D. (2013) · Current Oncology · doi:10.3747/co.20.1417 · Cited by 34
Inactivation of X-Linked Tumor Suppressor Genes in Human Cancer
Liu, R., Kain, M., & Wang, L. (2012) · Future Oncology · doi:10.2217/fon.12.26 · Cited by 34
Chen, I.-P., Henning, S. W., Faust, A., Boukamp, P., Volkmer, B., & Greinert, R. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp05197k · Cited by 37
Dermatology today and tomorrow: from symptom control to targeted therapy
Blume‐Peytavi, U., Bagot, M., Tennstedt, D., Aroman, M. S., Stockfleth, E., Zlotogorski, A., Mengeaud, V., Schmitt, A.-M., Paul, C. F., Lim, H. W., et al. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15335 · Cited by 36
Ceritinib Enhances the Efficacy of Trametinib in BRAF/NRAS -Wild-Type Melanoma Cell Lines
Verduzco, D., Kuenzi, B. M., Kinose, F., Sondak, V. K., Eroglu, Z., Rix, U., & Smalley, K. S. M. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0196 · Cited by 33
Molecular Chaperone Hsp90 Regulates REV1-Mediated Mutagenesis
Pozo, F. M., Oda, T., Sekimoto, T., Murakumo, Y., Masutani, C., Hanaoka, F., & Yamashita, T. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05117-11 · Cited by 34
MAGI1, a Scaffold Protein with Tumor Suppressive and Vascular Functions
Wörthmüller, J., & Rüegg, C. (2021) · Cells · doi:10.3390/cells10061494 · Cited by 36
Current and Emerging Molecular Therapies for Head and Neck Squamous Cell Carcinoma
Kordbacheh, F., & Farah, C. S. (2021) · Cancers · doi:10.3390/cancers13215471 · Cited by 34
Journeys into the genome of cancer cells
Stratton, M. R. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202388 · Cited by 33
Self-citationSimple and Efficient Methods for Enrichment and Isolation of Endonuclease Modified Cells
Moriarity, B. S., Rahrmann, E. P., Beckmann, D. A., Conboy, C. B., Watson, A. L., Carlson, D. F., Olson, E. R., Hyland, K. A., Fahrenkrug, S. C., McIvor, R. S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096114 · Cited by 33
Frequent TERT Promoter Mutations in Ocular Surface Squamous Neoplasia
Scholz, S. L., Thomasen, H., Reis, H., Möller, I., Darawsha, R., Müller, B., Dekowski, D., Sucker, A., Schilling, B., Schadendorf, D., et al. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17469 · Cited by 33
Metabotypes of breast cancer cell lines revealed by non-targeted metabolomics
Dubuis, S., Baenke, F., Scherbichler, N., Alexander, L. T., Schulze, A., & Zamboni, N. (2016) · Metabolic Engineering · doi:10.1016/j.ymben.2016.12.009 · Cited by 33
He, Y., Yu, X., Zhang, M., & Guo, W. (2021) · World Journal of Surgical Oncology · doi:10.1186/s12957-021-02342-y · Cited by 32
Hedgehog signalling pathway inhibitors as cancer suppressing agents
Trinh, T. N., McLaughlin, E. A., Gordon, C. P., & McCluskey, A. (2013) · MedChemComm · doi:10.1039/c3md00334e · Cited by 32
Discovery of structural alterations in solid tumor oligodendroglioma by single molecule analysis
Ray, M., Goldstein, S., Zhou, S., Potamousis, K. D., Sarkar, D., Newton, M. A., Esterberg, E. J., Kendziorski, C. M., Bögler, O., & Schwartz, D. C. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-505 · Cited by 32
Polyomavirus BK and prostate cancer: an unworthy scientific effort?
Delbue, S., Ferrante, P., & Provenzano, M. (2014) · Oncoscience · doi:10.18632/oncoscience.32 · Cited by 32
Nagashima, S., Kodaka, M., Iwasa, H., & Hata, Y. (2015) · The Journal of Biochemistry · doi:10.1093/jb/mvv009 · Cited by 31
Toward the Single-Hour High-Quality Genome
Ståhl, P. L., & Lundeberg, J. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060410-094158 · Cited by 32
Metadata
- Authors
- Pleasance, E. D., Cheetham, R. K., Stephens, P. J., McBride, D. J., Humphray, S. J., Greenman, C. D., Varela, I., Lin, M.-L., Ordóñez, G. R., Bignell, G. R., Ye, K., Alipaz, J., Bauer, M. J., Beare, D., Butler, A., Carter, R. J., Chen, L., Cox, A. J., Edkins, S., Kokko-Gonzales, P. I., Gormley, N. A., Grocock, R. J., Haudenschild, C. D., Hims, M. M., James, T., Jia, M., Kingsbury, Z., Leroy, C., Marshall, J., Menzies, A., Mudie, L. J., Ning, Z., Royce, T., Schulz-Trieglaff, O. B., Spiridou, A., Stebbings, L. A., Szajkowski, L., Teague, J., Williamson, D., Chin, L., Ross, M. T., Campbell, P. J., Bentley, D. R., Futreal, P. A., & Stratton, M. R.
- Affiliations
- Wellcome Sanger Institute (GB)
- Illumina (United Kingdom) (GB)
- Leiden University Medical Center (NL)
- Illumina (United States) (US)
- Dana-Farber Cancer Institute (US)
- Institute of Cancer Research (GB)
- Corresponding author
- Futreal, P. Andrew
- Stratton, Michael R.
- ORCID
- Pleasance, Erin D.
- McBride, David J.
- Humphray, Sean J.
- Greenman, Chris D.
- Varela, Ignacio
- Lin, Meng-Lay
- Ye, Kai
- Bauer, Markus J.
- Chen, Lina
- Edkins, Sarah
- James, Terena
- Jia, Mingming
- Marshall, John
- Menzies, Andrew
- Ning, Zemin
- Spiridou, Anastassia
- Teague, Jon
- Ross, Mark T.
- Campbell, Peter J.
- Futreal, P. Andrew
- Stratton, Michael R.
- Venue
- Nature
- Published
- 2009-12-16
- Volume
- 463
- Issue
- 7278
- Pages
- 191-196
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3145108
- OpenAlex
- W2150677022
- Cited by
- 1,696
- References
- 43
- Citations by year
- 2026: 23 · 2025: 47 · 2024: 43 · 2023: 49 · 2022: 50 · 2021: 83 · 2020: 76 · 2019: 87 · 2018: 69 · 2017: 94 · 2016: 121 · 2015: 116 · 2014: 144 · 2013: 166 · 2012: 189
- FWCI
- 58.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Wellcome Trust (077012/Z/05/Z, 077012, 088340, 093867)
- Kay Kendall Leukaemia Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- somatic mutations, mutational signatures, melanoma, lymphoblastoid cell lines, DNA repair, small cell lung cancer, tobacco smoke carcinogens, driver mutations, passenger mutations, cancer genome evolution
- MeSH terms
- Adult, DNA Damage, DNA Mutational Analysis, DNA Repair, Humans, Male, Melanoma, Mutation, Neoplasms, Ultraviolet Rays, Genome, Human, Mutagenesis, Insertional, Sequence Deletion, Gene Dosage, Loss of Heterozygosity, Polymorphism, Single Nucleotide, MicroRNAs, Cell Line, Tumor, Genes, Neoplasm, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
